Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jul 2;20(1):336.
doi: 10.1186/s13023-025-03769-2.

Sturge Weber syndrome in a multinational pediatric cohort: a systematic analysis of different types

Affiliations
Observational Study

Sturge Weber syndrome in a multinational pediatric cohort: a systematic analysis of different types

Sigrid Disse et al. Orphanet J Rare Dis. .

Abstract

Background: Sturge-Weber Syndrome (SWS) is characterized by leptomeningeal capillary malformation (CM), glaucoma, and facial vascular birthmark. The Roach Scale differentiates between cases with facial birthmark (Roach Type I) versus isolated brain involvement (Type III). Most previous studies have focussed on classic SWS Type I, but Type III cases were mostly described in case reports. We systematically compare cases with and without facial birthmark, with a focus on epilepsy variables, cerebral involvement and overall outcome.

Methods: Using a cross-sectional observational study conducted through a well-established child neurologists' network, we recruited pediatric patients with clinically diagnosed SWS from Germany, Switzerland, and Austria. The patients' guardians and attending child neurologists filled in detailed questionnaires. All patients were classified according to the Roach classification by both attending child neurologists and the study team.

Results: Our study identified 47 pediatric SWS patients (participation rate 43.2%). 35 cases (74.5%) fulfilled the criteria for classic SWS; six cases (12.8%) showed no skin involvement, the remaining cases were overlap/atypical phacomatoses with leptomeningeal and facial CM. Male/female ratio was 1.14, age ranged between 115 days and 17 years. Cases without facial birthmark were older at diagnosis (p = 0.005), and none showed ophthalmologic involvement. Comparison of age at first seizure did not reach significance after adjustment (p = 0.026). There was no significant difference between SWS types with regard to seizure types or frequency number of antiseizure medication (ASM), epilepsy surgery, cerebral involvement, SWS neuroscores. Multivariable analysis showed that, seizure frequency was independent of SWS type and epilepsy surgery, but was positively associated with the number of ASM required for seizure control (p = 0.0056). 50% of operated patients were seizure-free at study inclusion.

Conclusions: Type I and Type III SWS cases showed comparable profiles with regard to different epilepsy features, SWS neuroscores and number of used ASM. Type III patients were older at diagnosis and showed no ophthalmologic involvement, compatible with a milder SWS phenotype. Only few patients were evaluated for surgery, despite uncontrolled, structural epilepsy. Larger cohorts are needed to reevaluate the effectiveness of surgical therapies in different SWS types.

Keywords: Facial portwine birthmark; Observational study; Phacomatosis; Roach classification; Sturge-Weber Syndrome.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study protocol was approved by the responsible Institutional Review Board in Saarbrücken, University of Saarland, Germany (ID 209/17, October 2017).. The patients’ legal guardians gave informed consent in 44 cases. Three cases were sent anonymously by their attending child neurologists. As all data were stored anonymously, the above-named responsible Institutional Review Board in Saarbrucken, Germany waived informed consent in these cases (02/2023). All tables and texts which present single patients in detail include only patients whose parents/caregivers gave informed consent. To conclude, all obtained data were used in accordance with the General Data Protection Regulation of the European Union (“Datenschutz-Grundverordnung”) and the responsible Institutional Review Board. Consent for publication: All patients for which individual data are presented in this manuscript, gave informed consent to participation in our study and publication of their data. Competing interests: All authors declare that they have no competing financial interests.

Similar articles

References

    1. Roach ES. Neurocutaneous syndromes. Pediatr Clin N Am. 1992;39(4):591–620. - PubMed
    1. Phung T. Vascular Anomalies [cited 2025 Mar 27]. https://www.issva.org/UserFiles/file/ISSVAUpdatedflowdiagram_03152025_co....
    1. Aydin A, Cakmakçi H, Kovanlikaya A, Dirik E. Sturge-Weber syndrome without facial nevus. Pediatr Neurol. 2000;22(5):400–2. - PubMed
    1. Jordan PR, Iqbal M, Prasad M. Sturge-Weber syndrome type 3 manifesting as 'Status migrainosus'. BMJ Case Rep. 2016; 2016. - PMC - PubMed
    1. Ferrari L, Coppi E, Caso F, Santangelo R, Politi LS, Martinelli V, et al. Sturge–Weber syndrome with an unusual onset in the sixth decade: a case report. Neurol Sci. 2012;33(4):949–50. - PubMed

Publication types

LinkOut - more resources